Schlosser Mario sold $1.5M of OSCR (indirect holdings)
Schlosser Mario sold 47,500 indirectly-held shares of Oscar Health, Inc. (OSCR) at an average of $31.24 ($29.50–$31.65, $1.48M total) across 3 trades on 2026-07-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed open-market sale of 47,500 shares on July 1, 2026, totaling $1,484,013.80, with holdings reduced to 0 shares and executed under a pre-arranged 10b5-1 plan.
Market read
Traders may monitor for follow-on insider activity, but this specific filing alone is unlikely to drive a major repricing without additional company-specific catalysts.
What to watch
The disclosure is indirect holdings and shows zero shares after the transaction, but the article provides no context on total remaining exposure, tax considerations, or whether other insiders are selling/buying concurrently.
Background
The article is an SEC Form 4 insider transaction report for Oscar Health, Inc. (OSCR).
Ticker impact
Oscar Health director Mario Schlosser sold 47,500 shares in open-market transactions totaling about $1.48M under a 10b5-1 plan.
Likely limited near-term impact; any effect should be small and transient unless follow-on filings show continued selling or other new company news.
The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan and no accompanying operational/regulatory/financial update in the text.
Market effects
Minimal; single-insider 10b5-1 sale does not materially change the health-insurance/insurtech risk outlook.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations; traders may discount it.
Key entities
- issuerOscar Health, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderMario Schlosser
Director who sold shares via open-market transactions under a 10b5-1 plan.
